With the latest infusion of capital, RISA Labs plans to scale its product development efforts and expand deployments with hospitals and cancer care networks across the US healthcare system.
RISA Labs, an AI-driven healthtech startup, has secured USD 11.1 million in a funding round co-led by Cencora Ventures and Optum Ventures.
The round also saw participation from Oncology Ventures, Z21 Ventures, Ventureforgood founder John Simon, and existing investor Binny Bansal, co-founder of Flipkart.
The company had earlier raised USD 3.5 million in seed funding in April last year. With the latest infusion of capital, RISA Labs plans to scale its product development efforts and expand deployments with hospitals and cancer care networks across the US healthcare system.
Founded in 2024 by Kshitij Jaggi and Kumar Shivang, RISA Labs is building an AI operating system focused on cancer care. The startup offers a platform called BOSS, or Business Operating System as a Service, which uses AI agents, large language models, and digital twins to automate administrative workflows by breaking them into smaller tasks.
A key focus area for the company is addressing prior authorisation delays in oncology treatment, which often slow access to care for cancer patients. By automating clinical and administrative workflows, the platform aims to improve coordination between providers and accelerate treatment decisions.
RISA Labs targets oncology providers managing workflows related to diagnostics, treatment planning, approvals, and patient coordination. Indian companies also working on AI-led healthcare workflows include Innovaccer, Qure.ai, Predible Health, and Onco.com.
Stay tuned for more such updates on Digital Health News
Source link
